Castleark Management’s Covista Inc CVSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-84,520
Closed -$3M 276
2022
Q4
$3M Buy
84,520
+1,310
+2% +$51.1K 0.16% 140
2022
Q3
$3.03M Buy
+83,210
New +$3.18M 0.17% 131
2018
Q3
Sell
-316,062
Closed -$15.2M 378
2018
Q2
$15.2M Sell
316,062
-10,345
-3% -$495K 0.47% 61
2018
Q1
$15.5M Buy
326,407
+154,790
+90% +$7.24M 0.49% 53
2017
Q4
$7.22M Sell
171,617
-68,608
-29% -$2.69M 0.22% 148
2017
Q3
$8.61M Sell
240,225
-190,215
-44% -$6.5M 0.27% 135
2017
Q2
$16.3M Buy
430,440
+128,840
+43% +$4.8M 0.53% 48
2017
Q1
$10.7M Buy
301,600
+2,265
+0.8% +$74.8K 0.34% 100
2016
Q4
$9.34M Buy
+299,335
New +$8.1M 0.3% 109

Other funds holding CVSA

Castleark Management's CVSA Position: Q1 2023 in Review

Castleark Management sold out of Covista Inc (CVSA) in Q1 2023, closing a stake of 84,520 shares — an estimated $3M sold.

Castleark Management first reported a position in CVSA in Q4 2016 and held it in 9 quarters. The position peaked at $16.3M in Q2 2017. 191 funds tracked by Wall St. Rank hold CVSA as of Q1 2023.

  • Castleark Management reported no remaining Covista Inc position as of Q1 2023 after selling out during the quarter.
  • Castleark Management sold 84,520 Covista Inc shares in Q1 2023, an estimated $3M.
  • Castleark Management first reported a position in Covista Inc in Q4 2016 and held it in 9 quarters.
  • Castleark Management's Covista Inc position peaked at $16.3M in Q2 2017.
  • 191 funds tracked by Wall St. Rank held Covista Inc as of Q1 2023.

Based on Castleark Management's 13F filing for Q1 2023, filed 16 May 2023.